InsiderTrades.com logo
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.

BBIO Insider Trading

Insider Ownership Percentage: 24.66%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $155,346,267.36

BridgeBio Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at BridgeBio Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BridgeBio Pharma Share Price & Price History

Current Price: $23.04
Price Change: ▲ Price Increase of +0.5 (2.22%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for BBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
From Darwin   |   Ad
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
👉 Click here to access your FREE report now!

BridgeBio Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2024Brian C. StephensonCFOSell4,156$22.41$93,135.9693,758View SEC Filing Icon  
11/19/2024Neil KumarCEOSell27,389$22.41$613,787.494,897,443View SEC Filing Icon  
9/13/2024Genetic Disorder L.P. KkrMajor ShareholderSell5,800,000$25.75$149,350,000.0025,260,971View SEC Filing Icon  
8/19/2024Brian C. StephensonCFOSell4,155$24.69$102,586.9585,192View SEC Filing Icon  
8/19/2024Neil KumarCEOSell27,389$24.69$676,234.414,897,443View SEC Filing Icon  
6/3/2024Randal W. ScottDirectorSell1,000$28.84$28,840.005,500View SEC Filing Icon  
3/1/2024Randal W. ScottDirectorSell2,500$34.00$85,000.006,500View SEC Filing Icon  
1/16/2024Hannah ValantineDirectorSell2,915$37.97$110,682.551,764View SEC Filing Icon  
12/26/2023Frank McCormickDirectorSell100,000$42.06$4,206,000.00627,689View SEC Filing Icon  
12/18/2023Randal W. ScottDirectorSell2,000$40.00$80,000.009,000View SEC Filing Icon  
8/17/2023Brian C. StephensonCFOSell22,683$28.59$648,506.9736,710View SEC Filing Icon  
8/17/2023Neil KumarCEOSell51,552$28.59$1,473,871.684,813,197View SEC Filing Icon  
7/18/2023Global Investors Lp VikingMajor ShareholderSell1,500,000$35.00$52,500,000.0025,120,991View SEC Filing Icon  
5/17/2023Brian C. StephensonCFOSell24,424$14.01$342,180.2436,408View SEC Filing Icon  
5/17/2023Neil KumarCEOSell51,552$14.01$722,243.524,813,197View SEC Filing Icon  
4/5/2023Brian C. StephensonCFOSell55,500$15.45$857,475.00101,337View SEC Filing Icon  
4/5/2023Neil KumarCEOSell120,000$15.46$1,855,200.001,132,722View SEC Filing Icon  
3/3/2023Brian C. StephensonCFOSell62,692$10.96$687,104.32156,837View SEC Filing Icon  
3/3/2023Neil KumarCEOSell120,000$10.96$1,315,200.001,252,722View SEC Filing Icon  
2/17/2023Brian C. StephensonCFOSell17,717$12.70$225,005.90219,529View SEC Filing Icon  
2/17/2023Neil KumarCEOSell44,798$12.70$568,934.604,813,197View SEC Filing Icon  
2/3/2023Brian C. StephensonCFOSell61,040$11.01$672,050.40219,184View SEC Filing Icon  
2/3/2023Neil KumarCEOSell120,000$11.01$1,321,200.001,372,722View SEC Filing Icon  
1/5/2023Brian C. StephensonCFOSell61,040$7.67$468,176.80280,224View SEC Filing Icon  
1/5/2023Neil KumarCEOSell120,000$7.67$920,400.001,492,722View SEC Filing Icon  
11/17/2022Brian C. StephensonCFOSell19,678$9.40$184,973.20341,264View SEC Filing Icon  
11/17/2022Neil KumarCEOSell34,640$9.40$325,616.004,813,197View SEC Filing Icon  
3/14/2022Douglas A. DachilleDirectorBuy10,000$8.19$81,900.00View SEC Filing Icon  
1/4/2022Douglas A. DachilleDirectorBuy5,000$16.82$84,100.00View SEC Filing Icon  
12/30/2021Ronald J. DanielsDirectorBuy10,402$14.34$149,164.68View SEC Filing Icon  
12/28/2021Ronald J. DanielsDirectorBuy11,745$12.73$149,513.85View SEC Filing Icon  
See Full Table
Trump won. Buy this coin now.
From Weiss Ratings   |   Ad
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
This could be his favorite coin.

SEC Filings (Institutional Ownership Changes) for BridgeBio Pharma (NASDAQ:BBIO)

99.85% of BridgeBio Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BridgeBio Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC3,413,949$86.94M0.0%+3.8%1.806%Search for SEC Filing on Google Icon
11/15/2024Frazier Life Sciences Management L.P.3,760,457$95.74M3.8%+3.5%1.990%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC545,008$13.88M0.0%+31.9%0.288%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd13,279$0.34M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP69,586$1.77M0.0%-95.3%0.037%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.842,644$21.45M3.4%-24.4%0.446%Search for SEC Filing on Google Icon
11/15/2024Quarry LP10,000$0.26M0.1%+33.3%0.005%Search for SEC Filing on Google Icon
11/15/2024Polar Asset Management Partners Inc.50,500$1.29M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/15/2024Melqart Asset Management UK Ltd403,485$10.27M0.9%+31.0%0.213%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC285,613$7.27M1.0%-15.5%0.151%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC4,818,012$122.66M0.1%+11.7%2.549%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC69,054$1.76M0.6%+54.9%0.037%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH140,225$3.50M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/14/2024Bellevue Group AG10,400$0.27M0.0%-18.8%0.006%Search for SEC Filing on Google Icon
11/14/2024Hhlr Advisors LTD.1,023,950$26.07M0.6%-26.4%0.545%Search for SEC Filing on Google Icon
11/14/2024Rockefeller Capital Management L.P.41,259$1.05M0.0%+11.7%0.022%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 1,532,224$39.01M0.0%-0.2%0.815%Search for SEC Filing on Google Icon
11/13/2024Dynamic Technology Lab Private Ltd15,029$0.38M0.0%N/A0.008%Search for SEC Filing on Google Icon
11/13/2024Daiwa Securities Group Inc.31,709$0.81M0.0%-11.2%0.017%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC136,447$3.47M0.1%+144.3%0.073%Search for SEC Filing on Google Icon
11/12/2024Eagle Asset Management Inc.11,201$0.30M0.0%-95.8%0.006%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.1,284,802$32.71M0.0%+8.0%0.683%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA737,367$18.77M0.0%+23.3%0.392%Search for SEC Filing on Google Icon
11/9/2024Primecap Management Co. CA906,724$23.09M0.0%-2.2%0.482%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC44,623$1.14M0.0%N/A0.024%Search for SEC Filing on Google Icon
11/8/2024Advisors Asset Management Inc.4,576$0.12M0.0%+56.1%0.002%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.12,148$0.31M0.0%N/A0.006%Search for SEC Filing on Google Icon
11/8/2024Jennison Associates LLC30,119$0.77M0.0%N/A0.016%Search for SEC Filing on Google Icon
11/8/2024B. Metzler seel. Sohn & Co. Holding AG36,603$0.93M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/7/2024First Turn Management LLC399,781$10.18M1.6%N/A0.213%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC31,173$0.79M0.1%+134.0%0.017%Search for SEC Filing on Google Icon
11/7/2024Swiss National Bank219,300$5.58M0.0%+1.1%0.117%Search for SEC Filing on Google Icon
11/6/2024Mizuho Markets Americas LLC87,180$2.22M0.0%+3.8%0.046%Search for SEC Filing on Google Icon
11/6/2024Royce & Associates LP121,955$3.11M0.0%N/A0.065%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.377,182$9.60M0.0%-1.4%0.201%Search for SEC Filing on Google Icon
11/5/2024WCM Investment Management LLC263,679$6.58M0.0%+49.2%0.140%Search for SEC Filing on Google Icon
11/4/2024State of New Jersey Common Pension Fund D76,586$1.95M0.0%+13.7%0.041%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.1,145,123$29.16M0.0%+1.8%0.609%Search for SEC Filing on Google Icon
10/29/2024Fernwood Investment Management LLC261,735$6.66M2.2%+2.4%0.139%Search for SEC Filing on Google Icon
10/29/2024Emerald Advisers LLC1,103,508$28.10M1.1%+65.6%0.587%Search for SEC Filing on Google Icon
10/29/2024Emerald Mutual Fund Advisers Trust751,355$19.13M1.0%+50.8%0.400%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.36,165$0.92M0.1%+64.5%0.019%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.6,801$0.17M0.0%+21.7%0.004%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.2,237$57K0.0%N/A0.001%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.24,134$0.61M0.0%-90.2%0.013%Search for SEC Filing on Google Icon
10/23/2024Moody Aldrich Partners LLC123,509$3.15M0.6%-1.8%0.066%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.38,043$0.97M0.0%-2.7%0.020%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC5,322$0.14M0.0%+17.7%0.003%Search for SEC Filing on Google Icon
10/11/2024Creative Planning31,264$0.77M0.0%N/A0.017%Search for SEC Filing on Google Icon
10/8/2024CWM LLC3,442$88K0.0%+132.9%0.002%Search for SEC Filing on Google Icon
10/7/2024Diversified Trust Co36,772$0.94M0.0%+3.0%0.020%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB32,550$0.83M0.0%+17.7%0.017%Search for SEC Filing on Google Icon
9/4/2024Ghisallo Capital Management LLC33,750$0.86M0.1%-50.0%0.018%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC1,215,346$30.79M0.7%-13.9%0.649%Search for SEC Filing on Google Icon
8/16/2024Quarry LP7,500$0.19M0.0%+27.1%0.004%Search for SEC Filing on Google Icon
8/16/2024Capital Impact Advisors LLC13,925$0.35M1.0%-5.7%0.007%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC55,848$1.42M0.0%-37.5%0.030%Search for SEC Filing on Google Icon
8/16/2024Frazier Life Sciences Management L.P.3,632,604$92.01M4.3%+6.4%1.941%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Fundamental Investments LLC167,839$4.25M0.1%N/A0.090%Search for SEC Filing on Google Icon
8/15/2024Lion Point Capital LP49,000$1.24M2.3%N/A0.026%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company1,534,972$38.88M0.0%+40.5%0.820%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC125,160$3.17M0.0%-3.7%0.067%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC252,793$6.40M0.0%N/A0.135%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP30,849$0.78M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/14/2024Xponance Inc.8,871$0.23M0.0%+25.5%0.005%Search for SEC Filing on Google Icon
8/14/2024HighVista Strategies LLC44,572$1.13M0.4%-21.2%0.024%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC27,177$0.69M0.0%-18.3%0.015%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC51,029$1.29M0.0%+1.1%0.027%Search for SEC Filing on Google Icon
8/13/2024Ensign Peak Advisors Inc1,646,202$41.70M0.1%+44.5%0.880%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd12,096$0.31M0.0%-26.9%0.006%Search for SEC Filing on Google Icon
8/12/2024Vanguard Personalized Indexing Management LLC10,202$0.26M0.0%+18.8%0.005%Search for SEC Filing on Google Icon
8/12/2024Amalgamated Bank4,863$0.12M0.0%+24.7%0.003%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.16,496$0.42M0.0%+12.1%0.009%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP73,230$1.86M0.0%+5.2%0.039%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA598,263$15.15M0.0%+57.9%0.320%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.4,500$0.11M0.0%-94.3%0.002%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.1,096,734$27.78M0.0%+20.0%0.586%Search for SEC Filing on Google Icon
8/8/2024State of New Jersey Common Pension Fund D67,361$1.71M0.0%-15.8%0.036%Search for SEC Filing on Google Icon
8/7/2024Headlands Technologies LLC1,905$48K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/7/2024Daiwa Securities Group Inc.35,709$0.90M0.0%+5,393.7%0.019%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC13,324$0.34M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/6/2024Emerald Advisers LLC666,344$16.88M0.7%-4.7%0.356%Search for SEC Filing on Google Icon
8/6/2024Emerald Mutual Fund Advisers Trust498,254$12.62M0.7%-0.4%0.266%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System30,857$0.78M0.0%+7.6%0.016%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.382,717$9.69M0.0%+9.9%0.205%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers221,403$5.61M0.0%+19.5%0.118%Search for SEC Filing on Google Icon
7/31/2024Mizuho Markets Americas LLC83,982$2.13M0.1%+13.0%0.045%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.1,125,145$28.50M0.0%+4.8%0.601%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.727,963$18.44M0.1%+75.3%0.389%Search for SEC Filing on Google Icon
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank25,072$0.64M0.0%+14.2%0.013%Search for SEC Filing on Google Icon
7/29/2024Bfsg LLC1,240$31K0.0%+175.6%0.001%Search for SEC Filing on Google Icon
7/20/2024China Universal Asset Management Co. Ltd.21,984$0.56M0.1%-34.9%0.012%Search for SEC Filing on Google Icon
7/20/2024Nisa Investment Advisors LLC31,878$0.81M0.0%-18.2%0.017%Search for SEC Filing on Google Icon
7/20/2024Hennion & Walsh Asset Management Inc.39,099$0.99M0.1%-72.9%0.021%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.246,895$6.25M0.0%+3,429.6%0.132%Search for SEC Filing on Google Icon
7/16/2024Diversified Trust Co35,713$0.91M0.0%+28.9%0.019%Search for SEC Filing on Google Icon
7/2/2024Transcend Capital Advisors LLC13,500$0.34M0.0%N/A0.007%Search for SEC Filing on Google Icon
5/17/2024Zimmer Partners LP73,200$2.26M0.0%+12.6%0.039%Search for SEC Filing on Google Icon
5/17/2024Comerica Bank38,514$1.19M0.0%+3,013.5%0.021%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System105,596$3.27M0.0%+7.3%0.056%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BridgeBio Pharma logo
BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. Its products in development programs include AG10, a next-generation oral small molecule near-complete TTR stabilizer that is in Phase 3 clinical trial for the treatment of TTR amyloidosis, or transthyretin amyloid cardiomyopathy (ATTR-CM); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 double-blinded, placebo-controlled pivotal study for the treatment option for children with achondroplasia; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 1/2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 3 clinical trial for treating autosomal dominant hypocalcemia type 1, or ADH1; and BBP-418, a glycosylation substrate pro-drug that is in Phase 3 clinical trial for treating limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). In addition, it engages in developing products for mendelian, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; and Leidos Biomedical Research, Inc. The company was founded in 2015 and is headquartered in Palo Alto, California.
Read More on BridgeBio Pharma

Today's Range

Now: $23.04
Low: $22.05
High: $23.16

50 Day Range

MA: $25.09
Low: $22.35
High: $27.09

52 Week Range

Now: $23.04
Low: $21.62
High: $44.32

Volume

1,395,889 shs

Average Volume

1,852,762 shs

Market Capitalization

$4.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Who are the company insiders with the largest holdings of BridgeBio Pharma?

BridgeBio Pharma's top insider investors include:
  1. Genetic Disorder LP Kkr (Major Shareholder)
  2. Global Investors Lp Viking (Major Shareholder)
  3. Neil Kumar (CEO)
  4. Frank Mccormick (Director)
  5. Brian C Stephenson (CFO)
  6. Randal W Scott (Director)
  7. Hannah Valantine (Director)
Learn More about top insider investors at BridgeBio Pharma.

Who are the major institutional investors of BridgeBio Pharma?

BridgeBio Pharma's top institutional investors include:
  1. Janus Henderson Group PLC — 2.55%
  2. Frazier Life Sciences Management L.P. — 1.99%
  3. Geode Capital Management LLC — 1.81%
  4. The Manufacturers Life Insurance Company — 0.81%
  5. Charles Schwab Investment Management Inc. — 0.68%
  6. Principal Financial Group Inc. — 0.61%
Learn More about top institutional investors of BridgeBio Pharma stock.

Which institutional investors are selling BridgeBio Pharma stock?

Within the previous quarter, BBIO stock was sold by these institutional investors:
  1. Wellington Management Group LLP
  2. Hhlr Advisors LTD.
  3. Sphera Funds Management LTD.
  4. Eagle Asset Management Inc.
  5. Assenagon Asset Management S.A.
  6. Jane Street Group LLC
  7. Ikarian Capital LLC
  8. Primecap Management Co. CA
Within the previous year, company insiders that have sold BridgeBio Pharma company stock include:
  1. Genetic Disorder LP Kkr (Major Shareholder)
  2. Global Investors Lp Viking (Major Shareholder)
  3. Neil Kumar (CEO)
  4. Frank Mccormick (Director)
  5. Brian C Stephenson (CFO)
  6. Randal W Scott (Director)
Learn More investors selling BridgeBio Pharma stock.

Which institutional investors are buying BridgeBio Pharma stock?

During the last quarter, BBIO stock was purchased by institutional investors including:
  1. Janus Henderson Group PLC
  2. Emerald Advisers LLC
  3. First Turn Management LLC
  4. Emerald Mutual Fund Advisers Trust
  5. Erste Asset Management GmbH
  6. Massachusetts Financial Services Co. MA
  7. Barclays PLC
  8. Frazier Life Sciences Management L.P.
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.